Abstract Background: Phyllodes tumors are rare fibroepithelial breast tumors with diverse biological behavior. Our study aim is to review the clinico-pathological features, prognostic factors and treatment outcome for patients presenting with phyllodes tumors of the breast to the Kuwait Cancer Control Center (KCCC). Patients and methods: We retrospectively reviewed the clinical and pathological data of 35 women of histologically proved phyllodes tumors of the breast retrieved between January 1994 and December 2012. Results: The median age was 40 years (21-63 years). The median pathological tumor size was 6.8 cm (3-25 cm). Histologically, one patient (3%) presented with benign, 13 (37%) with borderline and 21 (60%) with malignant phyllodes. Twenty-eight patients (80%) were premenopausal. Twenty (57%) were ultimately treated with mastectomy (3 borderline, and 17 malignant) and 15 (43%) with conservative surgery (1 benign, 10 borderline and 4 malignant). Axillary staging was carried out in 9 patients (1 borderline and 8 malignant), none of them had nodal metastasis. Four patients with malignant phyllodes received postoperative radiotherapy. After a median follow-up period of 52 months (range 5-211 months), 5 developed local recurrence (1 benign, 2 borderline and 2 malignant). One patient with malignant phyllodes developed distant lung metastasis. The overall 5-year relapse free survival (RFS) was 74% (68% for borderline and 84% for malignant phyllodes). According to the treatment modality, the 5-year RFS was 69% for conservative surgery compared to 87% for mastectomy. It was 100% for irradiated patients versus 71% for non irradiated patients. Conclusion: Phyllodes tumors are rare tumors that occur in relatively young women, when compared with the classical adenocarcinoma of the breast. They have a tendency to reach large sizes with absence of nodal metastasis. Although surgery is the mainstay of management, postoperative radiotherapy also appears to decrease the local recurrence rates in certain presentations.
Introduction
Phyllodes tumors are rare fibroepithelial breast tumors that account for fewer than 0.5% of all breast malignancies [1, 2] . They are characterized by a diverse range of biologic behavior. The least aggressive form may behave similar to fibroadenomas, yet with a high local recurrence rate if excised without wide margins, while its malignant form can give distant metastasis [3, 4] .
Phyllodes tumors are classified as benign, borderline or malignant [1, 3, 5] according to the degree of stromal cellular atypia, mitotic activity, infiltrative versus circumscribed tumor margins and presence or absence of stromal overgrowth [6] [7] [8] [9] . The stromal elements are key components in the differentiation of phyllodes tumors from fibroadenomas and in distinguishing a benign from a malignant phyllodes tumor [7] .
The main treatment of phyllodes tumors remains surgical excision. Wide local excision, with a margin of at least 1 cm is the most effective surgery [1, 4, 10] for nonmalignant as well as malignant lesions. Re-excision is indicated when necessary to ensure adequate margins as the recurrence rates are unacceptably high following excision with inadequate margins [11] [12] [13] [14] [15] [16] [17] . The local recurrence rates following wide local excision are 8% for benign phyllodes tumors and 21-36% for borderline and malignant tumors [10, 12] .
Adjuvant radiotherapy (RT) for phyllodes tumors is controversial. Radiotherapy is unnecessary for benign phyllodes tumors that are widely excised. However, adjuvant RT appears to be effective in decreasing recurrences after breast conserving resection for borderline or malignant phyllodes tumors [10, 14, 17 ] particularly when it is not possible to obtain a wide margin of P1 cm of resection. For some tumors a 1 cm margin may not be possible even with a total mastectomy due to their size or location. Available data indicate that RT will substantially reduce recurrence for these patients [10] . There is less agreement about the role of adjuvant RT when wide margins P1 cm can be obtained.
The benefit of adjuvant chemotherapy is controversial. It should be administered only for a minority of patients with large, high-risk or recurrent malignant tumors, and only after a thorough discussion about the risks and benefits of treatment. Hormone therapy is not effective for phyllodes tumors despite the presence of positive hormone receptors in the epithelial component of some of these tumors [18, 19] .
The majority of patients with benign and borderline phyllodes tumors are cured with surgery. The survival rate for malignant phyllodes tumors is reported as approximately 60-80% at 5 years [4, 11, 20] . Metastatic disease has been reported in 13-40% of patients [1, 3, 4] . Metastases most frequently involve the lungs. After the development of metastases, mean overall survival is 30 months [21] .
Aim of the study
This is a retrospective study that aims at revision of the clinicopathological features, prognostic factors and treatment outcome for patients who presented with phyllodes tumors of the breast to the Kuwait Cancer Control Center (KCCC).
Patients and methods
The medical index of the KCCC is a computerized record of all the diagnoses made or revised at the KCCC. The KCCC is the only multidisciplinary cancer center in the State of Kuwait to which all patients are referred from different provinces of Kuwait. A search of the index from January 1994 to December 2012, using the term phyllodes tumors, revealed 35 cases.
The clinical and pathological data were retrospectively studied from the medical and pathologic records. Disease free survival was estimated using Kaplan Meier method. DFS was defined as the time from diagnosis to the date of first recurrence. Patients without documented recurrent disease were censored at the last date of their follow up. Statistical significance was calculated by using the log-rank test and defined as P < 0.05.
Results
The characteristics of the 35 patients are summarized in Table 1 . All patients were females with a median age at diagnosis of 40 years (range 21-63). The median follow-up was 52 months (range 5-211 months). Twenty-eight (80%) were premenopausal. No patients reported family history of breast cancer. All patients presented with a breast mass, four with tumor ulceration. Mammography was employed in 11 patients, 5 were reported as BIRADS 3, 4 as BIRADS 4 and 2 as BIRADS 5. One patient presented with benign phyllodes, thirteen had borderline phyllodes (37%) and 21 had malignant phyllodes (60%). Initially 18 were subjected to conservative surgery however 7 showed inadequate surgical margin. Secondary surgery was wider excision in 4 and mastectomy in 3. Overall mastectomy was the definitive surgery in 20 (57%). Surgical axillary staging was performed in 9 patients (axillary sampling in 5 patients and formal dissection in 4 patients), all of them showed no nodal metastasis. The most frequent tumor site was the upper outer quadrant reported in 17 patients (48.5%) while the second frequent was the involvement of the whole breast in 11 patients (31.5%). The median pathologic tumor size was 6.8 cm (range 3-25 cm), however for ulcerative tumors it was 18 cm (range 12-25). Adjuvant RT was employed in 4 patients (following mastectomy in 3 patients and conservative surgery in one). The four patients presented with large malignant phyllodes tumors (median size of 16 cm). The dose of postmastectomy RT was 50 Gy/25 fractions in two and 60 Gy/30 fractions in the third. Following conservative surgery, the RT dose was 50 Gy/25 fractions + 14 Gy/7 fractions as a tumor bed boost. None of the 4 patients experienced local recurrence.
Local recurrence was experienced in 5 patients (one benign, 2 borderline and 2 malignant phyllodes). Histopathology of recurrence was similar to the original pathology in all cases. Two patients were treated with wide local excision and 3 with mastectomy. One patient treated for malignant phyllodes developed distant lung metastasis and lost follow-up. One patient who was treated for malignant phyllodes with wide excision and RT developed ipsilateral DCIS after 10 years and was managed with mastectomy (see Figs. 1-4) .
The relapse group had a median age of 37 years (25-63 years) and a median tumor size of 5 cm (3-16 cm).
The 5-year relapse free survival (RFS) was 74 ± 10%. It was 68 ± 20% for borderline and 84 ± 8% for malignant phyllodes (P = 0.9). The four patients who received adjuvant RT did not develop relapse (5-years RFS 71 ± 11% for non irradiated versus 100% for irradiated patients, P = 0.3). According to the type of surgery the 5-year RFS was 69 ± 14% for WLE versus 87 ± 9% for mastectomy patients (P = 0.4). 
Discussion
Phyllodes tumors are rare tumors with an average annual incidence rate of 2.1 per million women [6] . We retrieved 35 female patients diagnosed in KCCC in a 19 year period. Phyllodes tumors of the breast present in a younger age population compared to adenocarcinoma. The median age is 40 years compared to 52 years for breast adenocarcinoma in Kuwait [22] and comparable to the reported 42-45 years worldwide [6, 23, 25] . Phyllodes tumors are generally first identified as a breast mass or an abnormal mammographic finding. The median tumor size in our study is 5.7 cm, larger for malignant phyllodes (7.5 cm) compared to the borderline subtype (4 cm) likely due to more rapid growth pattern. Larger tumors ulcerated by pressure necrosis to the skin. The reported median size in the literature is 4-7 cm [1, 23] . However, for borderline and malignant phyllodes, Mallick et al. reported a median size of 13.6 cm [24] .
The typical appearance of a phyllodes tumor on mammography is a smooth, polylobulated mass resembling a fibroadenoma explaining why five out of the eleven mammographies done reported a probably benign mass (BIRADS 3). Generally, mammography was underused in our patients as many patients were managed in general hospitals and in the early 1990s. Also, many patients presented with locally advanced disease making the mammographic assessment of no value. Suspicion for a phyllodes tumor rather than a fibroadenoma is based on large tumor size at presentation or rapid growth [3] . Image guided core biopsy is now our standard of care before surgical management of any breast mass. Only one patient presented with benign phyllodes in our series while in many series, benign phyllodes represented 50% of phyllodes tumors [3, 8] . This may be explained by the reluctance of surgeons operating on benign phyllodes to refer patients to a cancer center. In our study, the probability of having a positive surgical margin after conservative surgery is higher with malignant phyllodes compared to borderline (24% vs. 15%) likely due to the infiltrative nature of the tumor. The overall mastectomy rate for the malignant phyllodes was 81% compared to 23% for the borderline secondary to larger tumor size and higher positive margin rate.
Despite axillary node metastases being rare (only eight of 498 women in the SEER database) [11] , nine patients had axillary surgical staging (sentinel lymph node biopsy in 3, axillary sampling in 2 and axillary dissection in 4) mostly for malignant phyllodes. None of them had nodal metastasis. Axillary dissection is not recommended, however many patients were referred to our center following surgery.
Adjuvant radiotherapy lowered the rates of local recurrence in malignant and borderline tumors [17] . Radiotherapy was underused in our study. It was employed in only 4 patients with large malignant tumors, none of them experienced local relapse.
The local recurrence rate was 14% comparable with the recurrence rates reported in the literature (8-19%) . In some reports, it reached to 36% [17] . Only one patient developed distant metastasis in our study, the reported rates of distant metastasis ranged from 2.4% to 7.5% [1, 14, 26, 27] . The number of patients who relapsed was relatively small. The tumor, patients and treatment characteristics were not significantly different between the relapsed and non relapsed groups.
The follow-up of our patients who were treated for phyllodes tumors follows the same breast cancer follow-up protocol as defined by NCCN guidelines [28] . However, a report from UK advices against routine follow up of these cases [29] .
Conclusion
Phyllodes tumors are rare tumors that occur in relatively young women, when compared with the classical adenocarcinoma of the breast. They have a tendency to reach large sizes with absence of nodal metastasis. Although surgery is the mainstay of management, postoperative radiotherapy also appears to decrease the local recurrence rates in certain presentations.
